On fractional order models for Hepatitis C by Ahmed, E & El-Saka, H A
DEBATE Open Access
On fractional order models for Hepatitis C
E Ahmed
1*, H A El-Saka
2
Abstract
In this paper we present a fractional order generalization of Perelson et al. basic hepatitis C virus (HCV) model
including an immune response term. We argue that fractional order equations are more suitable than integer order
ones in modeling complex systems which include biological systems. The model is presented and discussed. Also
we argue that the added immune response term represents some basic properties of the immune system and that
it should be included to study longer term behavior of the disease.
1. Introduction
Hepatitis C is one of many serious infectious diseases
affecting humans. An estimated about 170 million people
worldwide are infected with hepatitis C. No vaccine
against hepatitis C is available. Egypt has the highest rate
of infections by hepatitis C virus (HCV) genotype 4.
Chronic HCV infection is the main cause leading to liver
transplant or death [1]. Antiviral therapy has been used
to treat chronically HCV infected patients. Relatively suc-
cessful treatment contains pegylated interferon (PEG-
IFN) and ribavirin (RBV). Typical response ate biphasic
beginning with rapid viral decline phase followed by
slower decline phase. Sometimes there is more compli-
cated behavior but they will not be discussed here. Exten-
sive and impressive studies have been done by Perelson
and his group [2-5]. Here we present a fractional order
generalization of a basic HCV model [2] including the
immune response (Ir) term proposed in [3].
In sec. 2 we argue that fractional order equations are
more suitable than integer order ones in modeling com-
plex systems which include biological systems. In sec.3
the model is presented and discussed. Also we argue
that the added immune response term represents some
basic properties of the immune system and that it
should be included to study longer term behavior of the
disease.
2. Fractional Equations
Caputo’s definition for derivative of order 0 < a ≤ 1i s
given by [6]
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where Γ (a)i st h eG a m m af u n c t i o na n df’(s)i st h e
first derivative. It is known that FO is more suitable in
describing complex adaptive systems e.g. biological sys-
tems since they naturally represent fractal, memory and
non-locality effects [7-9].
3. The model and conclusions
The fractional order hepatitis C virus (HCV) model is
given by
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Where 0 < a ≤ 1, T represents uninfected hepatocytes,
I represents infected hepatocytes and V represents virus.
The model assumes that uninfected hepatocytes are pro-
duced at a constant rate s, die at rate, d, per cell and are
infected at constant rate b. Infected hepatocytes are lost
at a rate δ per cell. Viral particles (virions) are produced
at rate p per infected hepatocyte and cleared at rate c
per virion. Chronic HCV infection is treated using inter-
feron-a in combination with the antiviral drug ribavirin.
Interferon-a acts primarily by blocking the production/
release of new virus, although we also allow for a treat-
ment effect in blocking de novo infection. The efficacy
of treatment in blocking virion production and reducing
new infections are described by two parameters, εp and
h, respectively. For example, a treatment efficacy in
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εp = 0.95.
The approximate solutions displayed in Figs. 1, 2, 3
for different a and s =2 . 6×1 0
4, d = 0.0026, h = 0.95,
b =2 . 2 5×1 0
-7, δ = 0.26, c2 =5×1 0
6, c =6 . 0 ,
εp = 0.99, p = 2.9
We have the following conclusions:
i) Mathematical models, when done by a group of
mathematicians and HCV specialists give relevant
results e.g. explaining the role of RBV [4], explaining
the observed two phase decline hence deriving the
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Page 2 of 3role of the drug in initially blocking the viral secre-
tion more than blocking the cells’ infection etc. [4].
ii) The term added in equation (1) represents the
well known high and low zone tolerance of the
immune response (There is no Ir if the antigen
number is either too high or too low [10]) since it
vanishes for both limits I ® 0a n dI ® c2. Immune
response is significant for long time virus dynamics.
iii) Fractional order results show the realistic bipha-
sic decline behavior of HCV but at a slower rate.
iv) Since multi-drugs are strongly recommended to
a v o i dd r u gr e s i s t a n c ei ti sp r o p o s e dt h a taf u r t h e r
drug should be used in addition to Peg-IFN and
RBV. Notice that RBV may not be considered as
independent drug since, when used alone, it has no
effect on HCV.
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